Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Price

Showing results (211-220 of 261) with videos related to

Pageof 27
Sort By:
Circulation. Cardiovascular Interventions|July 13, 2019
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary InterventionChristoph B Olivier, Deepak L Bhatt, Sergio Leonardi, et al.
European Heart Journal. Acute Cardiovascular Care|August 4, 2016
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experienceSergio Leonardi, Renato D Lopes, Ph Gabriel Steg, et al.
Circulation. Cardiovascular Interventions|April 14, 2020
Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II StudyMitchell W Krucoff, Philip Urban, Jean-François Tanguay, et al.
Journal of the American College of Cardiology|May 5, 2022
Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial FibrillationJames V Freeman, Angela Y Higgins, Yongfei Wang, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Sex-Specific Outcomes After Coronary Intravascular Lithotripsy: A Patient-Level Analysis of the Disrupt CAD StudiesYasin Hussain, Kathleen E Kearney, J Dawn Abbott, et al.
Journal of the American College of Cardiology|November 5, 2013
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)Philippe Généreux, Gregg W Stone, Robert A Harrington, et al.
Clinical Cardiology|June 30, 2019
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIXCelina M Yong, Vandana Sundaram, Freddy Abnousi, et al.
Journal of the American Heart Association|February 15, 2023
Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX TrialShephal K Doshi, Saibal Kar, Ashish Sadhu, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific OutcomesJennifer Frampton, Kathleen E Kearney, J Dawn Abbott, et al.
International Journal of Cardiology|June 26, 2018
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trialsChristoph B Olivier, Vandana Sundaram, Deepak L Bhatt, et al.
Pageof 27

Showing results (211-220 of 261) with videos related to

Sort By:
Pageof 27
Circulation. Cardiovascular Interventions|July 13, 2019
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary InterventionChristoph B Olivier, Deepak L Bhatt, Sergio Leonardi, et al.
European Heart Journal. Acute Cardiovascular Care|August 4, 2016
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experienceSergio Leonardi, Renato D Lopes, Ph Gabriel Steg, et al.
Circulation. Cardiovascular Interventions|April 14, 2020
Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II StudyMitchell W Krucoff, Philip Urban, Jean-François Tanguay, et al.
Journal of the American College of Cardiology|May 5, 2022
Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial FibrillationJames V Freeman, Angela Y Higgins, Yongfei Wang, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Sex-Specific Outcomes After Coronary Intravascular Lithotripsy: A Patient-Level Analysis of the Disrupt CAD StudiesYasin Hussain, Kathleen E Kearney, J Dawn Abbott, et al.
Journal of the American College of Cardiology|November 5, 2013
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention)Philippe Généreux, Gregg W Stone, Robert A Harrington, et al.
Clinical Cardiology|June 30, 2019
The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIXCelina M Yong, Vandana Sundaram, Freddy Abnousi, et al.
Journal of the American Heart Association|February 15, 2023
Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX TrialShephal K Doshi, Saibal Kar, Ashish Sadhu, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific OutcomesJennifer Frampton, Kathleen E Kearney, J Dawn Abbott, et al.
International Journal of Cardiology|June 26, 2018
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trialsChristoph B Olivier, Vandana Sundaram, Deepak L Bhatt, et al.
Pageof 27